Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-allergic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drugs
1.2.3 Non-Oral Drugs
1.3 Market by Sales Channel
1.3.1 Global Anti-allergic Drugs Market Growth by Sales Channel: 2019 VS 2023 VS 2030
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-allergic Drugs Market Perspective (2019-2030)
2.2 Anti-allergic Drugs Growth Trends by Region
2.2.1 Global Anti-allergic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-allergic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-allergic Drugs Market Dynamics
2.3.1 Anti-allergic Drugs Industry Trends
2.3.2 Anti-allergic Drugs Market Drivers
2.3.3 Anti-allergic Drugs Market Challenges
2.3.4 Anti-allergic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-allergic Drugs Players by Revenue
3.1.1 Global Top Anti-allergic Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-allergic Drugs Revenue
3.4 Global Anti-allergic Drugs Market Concentration Ratio
3.4.1 Global Anti-allergic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-allergic Drugs Revenue in 2023
3.5 Anti-allergic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-allergic Drugs Product Solution and Service
3.7 Date of Enter into Anti-allergic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-allergic Drugs Breakdown Data by Type
4.1 Global Anti-allergic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-allergic Drugs Breakdown Data by Sales Channel
5.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2019-2024)
5.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030)
6 North America
6.1 North America Anti-allergic Drugs Market Size (2019-2030)
6.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-allergic Drugs Market Size by Country (2019-2024)
6.4 North America Anti-allergic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-allergic Drugs Market Size (2019-2030)
7.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-allergic Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-allergic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-allergic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-allergic Drugs Market Size (2019-2030)
9.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-allergic Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-allergic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-allergic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anti-allergic Drugs Introduction
11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Company Detail
11.2.2 Johnson And Johnson Business Overview
11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction
11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024)
11.2.5 Johnson And Johnson Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Anti-allergic Drugs Introduction
11.3.4 Merck Revenue in Anti-allergic Drugs Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Anti-allergic Drugs Introduction
11.4.4 Teva Revenue in Anti-allergic Drugs Business (2019-2024)
11.4.5 Teva Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Anti-allergic Drugs Introduction
11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Anti-allergic Drugs Introduction
11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 UCB Pharma
11.8.1 UCB Pharma Company Detail
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Anti-allergic Drugs Introduction
11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.8.5 UCB Pharma Recent Development
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Company Detail
11.9.2 Yangtze River Pharmaceutical Group Business Overview
11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction
11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024)
11.9.5 Yangtze River Pharmaceutical Group Recent Development
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Company Detail
11.10.2 Hainan Poly Pharm Business Overview
11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction
11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024)
11.10.5 Hainan Poly Pharm Recent Development
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Company Detail
11.11.2 Chongqing Huapont Pharmaceutical Business Overview
11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction
11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024)
11.11.5 Chongqing Huapont Pharmaceutical Recent Development
11.12 Dawnrays
11.12.1 Dawnrays Company Detail
11.12.2 Dawnrays Business Overview
11.12.3 Dawnrays Anti-allergic Drugs Introduction
11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024)
11.12.5 Dawnrays Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Non-Oral Drugs
Table 4. Global Anti-allergic Drugs Market Size Growth by Sales Channel (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anti-allergic Drugs Market Share by Region (2019-2024)
Table 8. Global Anti-allergic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anti-allergic Drugs Market Share by Region (2025-2030)
Table 10. Anti-allergic Drugs Market Trends
Table 11. Anti-allergic Drugs Market Drivers
Table 12. Anti-allergic Drugs Market Challenges
Table 13. Anti-allergic Drugs Market Restraints
Table 14. Global Anti-allergic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anti-allergic Drugs Market Share by Players (2019-2024)
Table 16. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
Table 17. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-allergic Drugs Product Solution and Service
Table 21. Date of Enter into Anti-allergic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-allergic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anti-allergic Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Anti-allergic Drugs Market Size by Sales Channel (2019-2024) & (US$ Million)
Table 28. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019-2024)
Table 29. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030) & (US$ Million)
Table 30. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2025-2030)
Table 31. North America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anti-allergic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Anti-allergic Drugs Product
Table 49. Sanofi Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Johnson And Johnson Company Detail
Table 52. Johnson And Johnson Business Overview
Table 53. Johnson And Johnson Anti-allergic Drugs Product
Table 54. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 55. Johnson And Johnson Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Anti-allergic Drugs Product
Table 59. Merck Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Teva Company Detail
Table 62. Teva Business Overview
Table 63. Teva Anti-allergic Drugs Product
Table 64. Teva Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 65. Teva Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Anti-allergic Drugs Product
Table 69. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Anti-allergic Drugs Product
Table 74. Bayer Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Sun Pharma Company Detail
Table 77. Sun Pharma Business Overview
Table 78. Sun Pharma Anti-allergic Drugs Product
Table 79. Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 80. Sun Pharma Recent Development
Table 81. UCB Pharma Company Detail
Table 82. UCB Pharma Business Overview
Table 83. UCB Pharma Anti-allergic Drugs Product
Table 84. UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 85. UCB Pharma Recent Development
Table 86. Yangtze River Pharmaceutical Group Company Detail
Table 87. Yangtze River Pharmaceutical Group Business Overview
Table 88. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
Table 89. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 90. Yangtze River Pharmaceutical Group Recent Development
Table 91. Hainan Poly Pharm Company Detail
Table 92. Hainan Poly Pharm Business Overview
Table 93. Hainan Poly Pharm Anti-allergic Drugs Product
Table 94. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 95. Hainan Poly Pharm Recent Development
Table 96. Chongqing Huapont Pharmaceutical Company Detail
Table 97. Chongqing Huapont Pharmaceutical Business Overview
Table 98. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product
Table 99. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 100. Chongqing Huapont Pharmaceutical Recent Development
Table 101. Dawnrays Company Detail
Table 102. Dawnrays Business Overview
Table 103. Dawnrays Anti-allergic Drugs Product
Table 104. Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 105. Dawnrays Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-allergic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-allergic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Drugs Features
Figure 4. Non-Oral Drugs Features
Figure 5. Global Anti-allergic Drugs Market Size Comparison by Sales Channel (2024-2030) & (US$ Million)
Figure 6. Global Anti-allergic Drugs Market Share by Sales Channel: 2023 VS 2030
Figure 7. Online Case Studies
Figure 8. Offline Case Studies
Figure 9. Anti-allergic Drugs Report Years Considered
Figure 10. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Anti-allergic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-allergic Drugs Market Share by Region: 2023 VS 2030
Figure 13. Global Anti-allergic Drugs Market Share by Players in 2023
Figure 14. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2023
Figure 16. North America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 18. United States Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 22. Germany Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Anti-allergic Drugs Market Share by Region (2019-2030)
Figure 30. China Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 38. Mexico Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 42. Turkey Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 45. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 46. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 49. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 50. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 51. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 52. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 53. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 54. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 55. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed